Summary: <p>This week, 2 new COVID-19 studies (doi:10.1001/jama.2020.6771 and doi: 10.1001/jama.2020.6775), an effective treatment for irritable bowel syndrome (<a href="https://www.ncbi.nlm.nih.gov/pubmed/31852769">https://www.ncbi.nlm.nih.gov/pubmed/31852769</a>), and trends in prostate cancer screening (<a href="https://www.ncbi.nlm.nih.gov/pubmed/31794057">https://www.ncbi.nlm.nih.gov/pubmed/31794057</a>).</p>
